UBC researchers have developed the first gene-editing treatment for skin conditions.
Safe, scalable and easy to apply topically, explore how the gene therapy could transform the treatment of skin disorders: https://t.co/siYI6xmPjs
UBC researchers have developed the first gene-editing treatment for skin conditions.
Safe, scalable and easy to apply topically, explore how the gene therapy could transform the treatment of skin disorders: https://t.co/siYI6xmPjs
I’m excited to speak at Nature Conferences this October. Join me and fellow researchers from across various disciplines to discuss insights on in vitro disease models and tissue engineering. Great line up of speakers! Abstract submissions welcome. 👉 https://t.co/Tl1NJ7nPQv
🚨👩🔬👨🔬🧪My lab is still looking for a postdoc to develop gene editing therapies for genetic skin diseases in beautiful Vancouver! If you like great science and the outdoors, this is the place to be: https://t.co/hxfQrvE1Zq
Together with @HedtrichLab we co-edited a special issue @ADDReditors about dermal drug delivery. Dont miss to read our Editorial, highlighting all the contributions to the issue. Thanks to all authors and to @krishansheora14 for designing the figure.
Link: https://t.co/8EscMm066K
University of British Columbia Recruitment ALERT! UBC Faculty position in Nucleic Acid Based Nanomedicine — Associate Professor or Professor | Departments of Biochemistry & Molecular Biology and Chemical & Biological Engineering. For application details: https://t.co/S1GEao8doZ
We’re looking for a postdoc to lead an exciting new collaborative project with @WilliamsLab_UBC! The focus is on studying the dynamics of immune cell glycosylation in the tumor microenvironment. See posting for more details. Please like and RT! https://t.co/WqErZ4W2aL
Organ-on-a-chip technologies can serve as models of #HumanBiology. @milicaruoft will begin a 3⃣-year stint at #mdcBerlin to take on the challenge of growing them with #vasculature.
Join us for her MDC-Lecture "Engineering Vascularized Organs-on-a-Chip" 👇
https://t.co/bAmsVNRKUa